Zolpidem Tartrate

Category
Hypnotic Sedative
Product code
99294-93-6

Zolpidem Tartrate is a non-benzodiazepine sedative-hypnotic active pharmaceutical ingredient widely used for the short-term treatment of insomnia, particularly for difficulties with sleep onset. By selectively modulating gamma-aminobutyric acid (GABA) receptors in the central nervous system, Zolpidem Tartrate promotes sedation and facilitates faster sleep initiation without significantly affecting sleep architecture. Pharmaceutical companies formulate Zolpidem Tartrate into oral tablets, sublingual tablets, and extended-release forms, providing flexible dosing options for diverse patient needs.

Common Zolpidem Tartrate Uses and Treated Conditions

  • Insomnia – Supports faster sleep onset in patients with difficulty falling asleep.
  • Short-Term Sleep Therapy – Used for transient or situational insomnia under medical supervision.
  • Sleep Initiation Support – Reduces sleep latency to improve overall sleep quality.
  • Extended-Release Therapy – Maintains sleep through the night for patients with middle-of-the-night awakenings.

Why Choose Cambrex as Your Generic API Manufacturer?

As a leading generic API supplier, Cambrex manufactures Zolpidem Tartrate API in cGMP-compliant facilities, ensuring every batch meets stringent global quality and regulatory standards. Our technical expertise, robust quality systems, and proven regulatory track record empower clients to accelerate development timelines and achieve successful market approvals. We prioritize transparency, reliability, and scientific rigor at every stage of the supply chain making us your trusted generic API manufacturer.

For detailed chemical information on Zolpidem Tartrate, visit the official CAS website.

If you’d like more information or to request a sample, contact our Generic API team today.

Zolpidem Tartrate

Cambrex your API partner

Cambrex are a leading global supplier of generic APIs. From our sites in Italy, Sweden, and the USA, we work with generic drug companies well in advance of drug patent expiration, using high quality, non-patent-infringing processes to manufacture APIs.

Contact us